Journal of Hematology & Oncology ( IF 29.5 ) Pub Date : 2021-09-23 , DOI: 10.1186/s13045-021-01154-7 Chunmeng Wang 1 , Fengxia Shi 1 , Yang Liu 1 , Yajing Zhang 1 , Liang Dong 1 , Xiang Li 1 , Chuan Tong 1 , Yao Wang 1 , Liping Su 2 , Jing Nie 1 , Weidong Han 1
The original article [1] contained a minor error in the Additional file which has since been corrected.
- 1.
Wang C, et al. Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy. J Hematol Oncol. 2021;14:106. https://doi.org/10.1186/s13045-021-01120-3.
CAS Article PubMed PubMed Central Google Scholar
Download references
Author notesJing Nie and Weidong Han jointly supervise this work
Chunmeng Wang and Fengxia Shi are co-first author
Affiliations
Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital, Beijing, China
Chunmeng Wang, Fengxia Shi, Yang Liu, Yajing Zhang, Liang Dong, Xiang Li, Chuan Tong, Yao Wang, Jing Nie & Weidong Han
Department of Hematology, Shanxi Cancer Hospital, Taiyuan, Shanxi, China
Liping Su
- Chunmeng WangView author publications
You can also search for this author in PubMed Google Scholar
- Fengxia ShiView author publications
You can also search for this author in PubMed Google Scholar
- Yang LiuView author publications
You can also search for this author in PubMed Google Scholar
- Yajing ZhangView author publications
You can also search for this author in PubMed Google Scholar
- Liang DongView author publications
You can also search for this author in PubMed Google Scholar
- Xiang LiView author publications
You can also search for this author in PubMed Google Scholar
- Chuan TongView author publications
You can also search for this author in PubMed Google Scholar
- Yao WangView author publications
You can also search for this author in PubMed Google Scholar
- Liping SuView author publications
You can also search for this author in PubMed Google Scholar
- Jing NieView author publications
You can also search for this author in PubMed Google Scholar
- Weidong HanView author publications
You can also search for this author in PubMed Google Scholar
Corresponding authors
Correspondence to Jing Nie or Weidong Han.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Reprints and Permissions
Cite this article
Wang, C., Shi, F., Liu, Y. et al. Correction to: Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy. J Hematol Oncol 14, 150 (2021). https://doi.org/10.1186/s13045-021-01154-7
Download citation
Published:
DOI: https://doi.org/10.1186/s13045-021-01154-7
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative